The global cell culture vessels market is entering a period of strong expansion, supported by rising demand for biologics, growing cell-based research, and increasing clinical development activity. The market was valued at USD 4.8 billion in 2025 and is expected to reach USD 5.3 billion in 2026. By 2033, the market is projected to expand to USD 13.7 billion, representing a 14.4% CAGR from 2026 to 2033.

North America accounted for the largest regional share, representing 36.42% of global revenue in 2025. Market growth is being driven by the increasing prevalence of chronic diseases, higher investments in pharmaceutical and biotechnology R&D, and the growing number of clinical trials involving cell-based therapies.

What Is Driving Cell Culture Vessels Market Growth?

Several structural trends are accelerating demand for cell culture vessels:

• Growing biologics production: Increasing manufacturing of monoclonal antibodies, vaccines, and other biologics is creating greater demand for reliable cell culture systems.
• Expansion of advanced therapies: Stem cell research, regenerative medicine, and cell and gene therapy are increasing the need for specialized culture vessels.
• Automation and single-use technologies: Pharmaceutical and biotechnology manufacturers are increasingly adopting automated workflows and single-use bioreactor systems to improve scalability, contamination control, and operational efficiency.
• Rising R&D expenditure: Greater investment in drug discovery, translational research, and clinical development is supporting the use of cell culture vessels across laboratories and production facilities.

Download a free sample report or claim your copy of this full market intelligence report

Market Segmentation

The cell culture vessels industry can be analyzed across products, applications, and end users.

By product: Culture flasks, multi-well plates, culture dishes, bioreactor vessels, roller bottles, and bags.

By application: Biopharmaceutical production, drug discovery, cell and gene therapy, and academic research.

By end user: Pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs).

Among product categories, the bags segment held the largest share at 39.47% in 2025. By type, single-use systems represented the leading segment in 2025. Pharmaceutical and biotechnology companies were the dominant end-user group, accounting for 46.54% of the market in 2025.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Market Landscape

North America remained the leading regional market, capturing 36.4% of global revenue in 2025. The region benefits from established biotechnology infrastructure, significant pharmaceutical R&D expenditure, advanced research capabilities, and strong adoption of cell-based technologies.

Asia Pacific is expected to record the fastest growth from 2026 to 2033, supported by expanding biopharmaceutical manufacturing capabilities, increasing research investments, and the development of healthcare and life sciences infrastructure.

Within individual countries, the U.S. cell culture vessels market is expected to grow significantly throughout the forecast period, reflecting sustained demand from pharmaceutical companies, biotechnology firms, research institutions, and advanced therapy developers.

Competitive Landscape

The cell culture vessels market includes established life sciences and laboratory technology companies competing through product innovation, portfolio expansion, manufacturing capabilities, and strategic partnerships.

Key companies include:

• Thermo Fisher Scientific Inc.
• STEMCELL Technologies
• Merck KGaA
• Greiner Bio-One International GmbH
• Corning Incorporated
• Wilson Wolf
• DWK Life Sciences

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.